2022. In Silico docking of piperazin analog for non-small cell lung cancer having mutations in EGFR, ALK, and BRAF proteins. Journal of Rashid Latif Medical College. 1, 2 (Dec. 2022). DOI:https://doi.org/10.69545/6tyx5a55.